Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
of course... he's probably just getting a selfie by the door on the way to the Nestle microbiome summit ... https://www.kisacoresearch.com/events/nestle-skin-health-skin-microbiome-summit
Hanging with the big nerds there ... "so we erm make skin and do AI to it" ;)
Thomas Dittrich joins Galderma as CFO, after co-leading Shire’s strong growth and cash flow generation as CFO. The Company’s Board is further reinvigorated with Thomas Ebeling, former CEO of Novartis Pharma, Novartis Consumer Health and ProSiebenSat1Media AG, joining as Chairman, and Sheri McCoy, former CEO of Avon Products and former Vice Chairman of Johnson & Johnson, where she was responsible for the pharma and consumer divisions, joining as a Director.
The new owners intend to advance the current direction taken by Galderma’s management and focus on accelerating growth further by building on the company’s leading market positions and brands in a sector benefiting from strong innovation and demographic trends.
Galderma will continue to invest in commercial excellence and innovation to meet the needs of health care professionals, patients, customers and consumers. The company will continue to increase presence in the US and China, launch new products and focus on international expansion. The company will keep its headquarters in Switzerland.
October 2, 2019
Galderma well positioned for long-term growth in highly attractive dermatology sector
Experienced management team and Board to build on strong Galderma foundations
Dr. Flemming Ornskov (ex-Shire and Bayer) appointed CEO and Thomas Dittrich appointed CFO (ex-Shire and Amgen)
Thomas Ebeling (ex-Novartis and ProSiebenSat1Media) appointed as Chairman of the Advisory Board
Sheri McCoy (ex-Avon Products and Johnson & Johnson) and outgoing CEO Stuart Raetzman to join the Advisory Board as Directors
Galderma (“the Company”), rebranded from Nestlé Skin Health, today debuts as the world’s largest independent global dermatology company following the completion of the CHF 10.2 billion acquisition, first announced in May 2019. The acquisition, led by a consortium comprising the EQT VIII fund (“EQT”), Luxinva (a wholly-owned subsidiary of Abu Dhabi Investment Authority, “ADIA”), PSP Investments and other renowned institutional investors, was completed following exclusive negotiations with Galderma’s previous owner, Nestlé S.A. (“Nestlé”).
Founded in 1981 and operated as a wholly owned subsidiary of Nestlé since 2014, Galderma offers a range of medical and consumer skin health solutions through three business units: Aesthetics, Prescription and Consumer Care, with combined revenues of CHF 2.8 billion and approximately 5,000 employees worldwide.
The Company will be led in its next phase of growth and innovation by an experienced Management Team and Board, with proven track records in building sustainable high-growth businesses in pharmaceutical and consumer industries.
Dr. Flemming Ornskov, MD, MPH assumes the position as CEO from Stuart Raetzman, who after having led Galderma and prepared the Company for its separation from Nestlé, now joins the Company’s Board. Flemming previously led the transformation of biopharmaceutical company Shire to become the global leader in rare diseases. Under his tenure, Shire grew from a USD 4 billion revenue business to USD 15 billion in five years, before the company was acquired by Takeda.
Flemming commented: “The management and team at Nestlé Skin Health have done an excellent job creating a high-growth, leading dermatology business. I believe that Galderma, as a newly focused pureplay dermatology business, has outstanding prospects built on its existing quality portfolio, team and rich pipeline of innovation. I look forward to working with the talented Galderma team to further build on its success to date.”
https://www.galderma.com/news/galderma-become-worlds-largest-independent-global-dermatology-company-after-completion-chf-102
very, very interesting given the recent (closed a few days ago) acquisition from Nestle by an investment consortium for over $10 billion...
"Nestlé sold its skin health unit to a consortium of investors led by EQT and a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for CHF 10.2 billion ($10.1 billion). Rebranded as Galderma, it will be the world’s largest independent global dermatology company."
https://beautymatter.com/2019/10/nestle-skin-health-sale-closes-for-10-1-billion/
ah yes ... he's obviously waiting to use the loos. Mad coincidence that the largest indepentent dermatology company in the world are in the same building.
Galderma ....could be very interesting. Look at the website and latest news
Looks to me that he is waiting for the toilets to open, judging by the sign on the door
is he there for the janitor job ? ... equipment is ready just inside the door.
Galderma - Nestle ... https://www.galderma.com/uk/
https://twitter.com/Labskin/status/1184015636042833920